RVPH - Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor Conference | Benzinga
CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO, and Narayan Prabhu, CFO of Reviva, will participate in The Benchmark Company's Discovery One-on-One Investor Conference, taking place December 7, 2023 in New York, NY.
The Benchmark Company's Discovery One-on-One Investor Conference
Format: One-on-one investor meetings
Date: Thursday, December 7, 2023
Location: New York Athletic Club in New York, NY
To register for the conference and schedule a one-on-one meeting with Reviva management, please use the link HERE.
About Reviva's Lead Drug Candidate Brilaroxazine
Brilaroxazine is an in-house discovered new ...